Sympathetic overactivity and sudden cardiac death among hemodialysis patients with left ventricular hypertrophy

International Journal of Cardiology

Volumn 142, Issue 1, 2010, Pages 80-86

  Nishimura, Masato ^a   Tokoro, Toshiko ^a   Nishida, Masasya ^a   Hashimoto, Tetsuya ^a   Kobayashi, Hiroyuki ^a   Yamazaki, Satoru ^a   Imai, Ryo ^a   Okino, Koji ^a   Iwamoto, Noriyuki ^a   Takahashi, Hakuo ^b   Ono, Toshihiko ^a  

^a Toujinkai Hospital   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Autonomic nervous system; Cardiac arrest; End stage renal disease; Heart rate variability; Mortality

Indexed keywords

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CALCULATION; COHORT ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE REVASCULARIZATION; HEART RATE VARIABILITY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOLTER MONITORING; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PARAMETER; PARASYMPATHETIC NERVE; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SUDDEN DEATH; SURVIVAL RATE; SYMPATHETIC TONE;

AGED; AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM DISEASES; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 77953277106     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.12.104     Document Type: Article

References (41)

1. Cheung A.K., Sarnak M.J., and Yan G. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO study. Kidney Int 65 (2004) 2380-2389
2. Wanner C., Krane V., and Marz W. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 (2005) 238-248
3. Deo R., Lin F., Vittinghoff E., Tseng Z.H., Hulley S.B., and Shlipak M.G. Kidney dysfunction and sudden cardiac death among women with coronary heart disease. Hypertension 51 (2008) 1578-1582
4. Collins A.J., Kasiske B., Herzog C., et al. United States Renal Data System 2006 annual data report: morbidity & mortality. Am J Kidney Dis 49 Suppl 1 (2007) S129-S146
5. Rea T.D., Pearce R.M., and Raghunathan T.E. Incidence of out-of-hospital cardiac arrest. Am J Cardiol 93 (2004) 1455-1460
6. Demirovic J., and Myerburg R.J. Epidemiology of sudden coronary death: an overview. Prog Cardiovasc Dis 37 (1994) 39-48
7. Foley R.N., Parfrey P.S., and Harnett J.D. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47 (1995) 186-192
8. Swynghedauw B., Chevalier B., Charlemagne D., Mansier P., and Carré F. Cardiac hypertrophy, arrhythmogenicity and the new myocardial phenotype. II. The cellular adaptational process. Cardiovasc Res 35 (1997) 6-12
9. Rials S.J., Wu Y., Xu X., Filart R.A., Marinchak R.A., and Kowey P.R. Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation 96 (1997) 1330-1336
10. Cameron J.S., Myerburg R.J., and Wong S.S. Electrophysiologic consequences of chronic experimentally induced left ventricular pressure overload. J Am Coll Cardiol 2 (1983) 481-487
11. Nordin C., Siri F., and Aronson R.S. Electrophysiologic characteristics of single myocytes isolated from hypertrophied guinea-pig hearts. J Mol Cell Cardiol 21 (1989) 729-739
12. Gillis A.M., Mathison H.J., Kulisz E., and Lester W.M. Dispersion of ventricular repolarization and ventricular fibrillation in left ventricular hypertrophy: influence of selective potassium channel blockers. J Pharmacol Exp Ther 292 (2000) 381-386
13. Tritthart H., Luedcke H., Bayer R., Stierle H., and Kaufmann R. Right ventricular hypertrophy in the cat - an electrophysiological and anatomical study. J Mol Cell Cardiol 7 (1975) 163-174
14. Keung E.C., and Aronson R.S. Non-uniform electrophysiological properties and electronic interaction in hypertrophied rat myocardium. Circ Res 49 (1981) 150-158
15. Ben-David J., Zipes D.P., Ayers G.M., and Pride H.P. Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of BAY K 8644. J Am Coll Cardiol 20 (1992) 1576-1584
16. Charpentier F., Baudet S., and Le Marec H. Triggered activity as a possible mechanism for arrhythmias in ventricular hypertrophy. Pacing Clin Electrophysiol 14 (1991) 1735-1741
17. Levy D., Anderson K.M., Savage D.D., Balkus S.A., Kannel W.B., and Castelli W.P. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Study. Am J Cardiol 60 (1987) 560-565
18. Ghali J.K., Kadakia S., Cooper R.S., and Liao Y.L. Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease. J Am Coll Cardiol 17 (1991) 1277-1282
19. Schmieder R.E., and Messerli F.H. Determinants of ventricular ectopy in hypertensive cardiac hypertrophy. Am Heart J 123 (1992) 89-95
20. Mammarella A., Paradiso M., and Basili S. Morphologic left ventricular patterns and prevalence of high-grade ventricular arrhythmias in the normotensive and hypertensive elderly. Adv Ther 17 (2000) 222-229
21. Haider A.W., Larson M.G., Benjamin E.J., and Levy D. Increased left ventricular mass and hypertrophy are associated with an increased risk for sudden death. J Am Coll Cardiol 32 (1998) 1454-1459
22. Converse Jr. R.L., Jacobsen T.N., and Toto R.D. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327 (1992) 1912-1918
23. Lown B., Tykocinski M., Garfein A., and Brooks P. Sleep and ventricular premature beats. Circulation 48 (1973) 691-701
24. Schwartz P.J., La Rovere M.T., and Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 85 1 Suppl (1992) I77-I91
25. Devereux R.B., Koren M.J., de Simone G., Okin P.M., and Kligfield P. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J 14 Suppl D (1993) 8-15
26. Hunt G.B., and Ross D.L. Influence of infarct age on reproducibility of ventricular tachycardia induction in a canine model. J Am Coll Cardiol 14 (1989) 765-773
27. Vos M.A., Verduyn S.C., and Gorgels A.P. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 91 (1995) 864-872
28. Vos M.A., de Groot S.H., and Verduyn S.C. Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation 98 (1998) 1125-1135
29. Cao J.M., Fishbein M.C., and Han J.B. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 101 (2000) 1960-1969
30. Kleiger R.E., Miller J.P., Bigger Jr. J.T., and Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59 (1987) 256-262
31. Farrell T.G., Bashir Y., and Cripps T. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 18 (1991) 687-697
32. La Rovere M.T., Bigger Jr. J.T., Marcus F.I., Mortara A., and Schwartz P.J. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351 (1998) 478-484
33. Tsuji H., Venditti Jr. F.J., and Manders E.S. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 90 (1994) 878-883
34. Hayano J., Takahashi H., and Toriyama T. Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant 14 (1999) 1480-1488
35. Beache G.M., Herzka D.A., and Boxerman J.L. Attenuated myocardial vasodilator response in patients with hypertensive hypertrophy revealed by oxygenation-dependent magnetic resonance imaging. Circulation 104 (2001) 1214-1217
36. Burke A.P., Farb A., Liang Y.H., Smialek J., and Virmani R. Effect of hypertension and cardiac hypertrophy on coronary artery morphology in sudden cardiac death. Circulation 94 (1996) 3138-3145
37. Zheng Z.J., Croft J.B., Giles W.H., and Mensah G.A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 104 (2001) 2158-2163
38. Silberberg J.S., Barre P.E., Prichard S.S., and Sniderman A.D. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36 (1989) 286-290
39. Paoletti E., Specchia C., and Di Maio G. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 19 (2004) 1829-1834
40. Nishimura M., Tsukamoto K., Hasebe N., Tamaki N., Kikuchi K., and Ono T. Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol 51 (2008) 139-145
41. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150